Biosensors & bioelectronics

Using a split CRISPR system to detect cancer early by identifying proteins on tiny cell-released particles

Updated

Abstract

The SPC-CRISPR system achieved a detection limit of 10 particles/μL for breast cancer exosomal proteins.

  • The system converts protein signals on exosomes into nucleic acid signals through a split proximity circuit.
  • Detection of phosphatidylserine, MUC1, and EpCAM on exosomes is facilitated by Tim4-modified magnetic beads and dual-aptamers.
  • In clinical tests, the system distinguished breast cancer patients from healthy donors with an area under the curve (AUC) of 0.9778 and an accuracy of 91.23%.
  • The system successfully detected stage 0 breast cancer with an accuracy of 92.59%.
  • It differentiated metastatic from non-metastatic cases with statistical significance (p < 0.001).
  • The method requires only 1 μL of serum and does not necessitate exosome isolation.

Simplified

Full Text

Full text is available at the source.

Funding

Competing interests

Declaration of competing interest The authors declare that they have no competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free